The EVRA trial outcome
wounds, wound care, Australia, professional, healthcare, expert, dressings, bandages, trauma, skin.
23154
post-template-default,single,single-post,postid-23154,single-format-standard,theme-stockholm,qode-social-login-1.1.3,stockholm-core-2.3.2,woocommerce-no-js,select-child-theme-ver-1.0.0,select-theme-ver-9.10,ajax_fade,page_not_loaded,,qode_menu_,qode-single-product-thumbs-below,wpb-js-composer js-comp-ver-6.13.0,vc_responsive
Title Image

The EVRA trial outcome

29 April 2018 In News By thewoundguy

The EVRA trial outcome

The New England Journal of Medicine has just published the outcomes of the EVRA (Early Venous Reflux Ablation) trial. The findings are that endovenous ablation of superficial venous reflux concurrent with compression when compared to compression therapy alone resulted in shorter venous ulcer healing times and reduced ulcer recurrence up to 12 months post wound closure. These benefits of ablation were even demonstrated when concomitant deep venous reflux was present.

Tags: